Managing Ptosis in Your Practice

AdminWolf

Site Administrator & Tech Lead
Staff member
Feb 24, 2001
15,370
2,797
113
School/Org
University of Michigan Medical School
City
Lake Oswego
State
OR
In this ODwire.org webinar, Melissa Barnett, OD and Susan Resnick, OD help us learn more about ptosis, including causes, diagnosis, treatment landscape, impact on patients, and opportunity for your practice.



Jason Bacharach, MD, introduces the first and only FDA-approved pharmacologic treatment for acquired blepharoptosis, RVL-1201 (oxymetazoline hydrochloride ophthalmic solution), 0.1%, including its mechanism of action and clinical data.

Continue reading...
 

Attachments

  • osmotica-webinar-july-2020.jpg
    osmotica-webinar-july-2020.jpg
    223 KB · Views: 684
Last edited:
  • Like
Reactions: Frederick Frost

AdminWolf

Site Administrator & Tech Lead
Staff member
Feb 24, 2001
15,370
2,797
113
School/Org
University of Michigan Medical School
City
Lake Oswego
State
OR
Looking forward to seeing everyone at the show. We're going to talk about RVL-1201, and as you may have heard, this is the first FDA-approved pharmacologic approach to treating Ptosis....

always fun to discuss something new!

-- ad
 

joel b. goldberg

ODwire.org Supporting Member
Feb 5, 2006
956
478
93
School/Org
Pennsylvania College of Optometry
City
monsey
State
ny
Looking forward to seeing everyone at the show. We're going to talk about RVL-1201, and as you may have heard, this is the first FDA-approved pharmacologic approach to treating Ptosis....

always fun to discuss something new!

-- ad

I can't listen live at that time unfortunately. Will it be recorded for posterity?
 

AdminWolf

Site Administrator & Tech Lead
Staff member
Feb 24, 2001
15,370
2,797
113
School/Org
University of Michigan Medical School
City
Lake Oswego
State
OR
I can't listen live at that time unfortunately. Will it be recorded for posterity?
Indeed, this one should be archived. Register for the live event, the system will send you an e-mail when the archive is available.

thanks
adam
 

Laurence Craig Thomas

ODwire.org Supporting Member
Sep 13, 2009
6,056
5,670
113
School/Org
University of Houston
City
Dallas
State
Tx
The representative for RVL came over today and did a lunch meeting with the staff.

He was cool young dude right out of college - said he had three days of training before today and I was his first call!

I told him not to worry - I would help him to learn about our profession.

He really seemed to appreciate that and we scheduled a meeting for two weeks from now.

He didn't even have samples to leave - said it just got approved 13 days ago.

Comically, my first patient after lunch had unilateral ptosis of unknown etiology. I told her of our lunch meeting and what was discussed in the office. She said that she wasn't surprised - she knew that God had sent her to me on this day and that I would take care of her problem.

She will be my first patient as soon as samples become available.

Anybody have any clinical experience yet with this new medicine?
 
Feb 9, 2008
1
1
3
School/Org
UC Berkeley School of Optometry
City
Sacramento
State
CA
The representative for RVL came over today and did a lunch meeting with the staff.

He was cool young dude right out of college - said he had three days of training before today and I was his first call!

I told him not to worry - I would help him to learn about our profession.

He really seemed to appreciate that and we scheduled a meeting for two weeks from now.

He didn't even have samples to leave - said it just got approved 13 days ago.

Comically, my first patient after lunch had unilateral ptosis of unknown etiology. I told her of our lunch meeting and what was discussed in the office. She said that she wasn't surprised - she knew that God had sent her to me on this day and that I would take care of her problem.

She will be my first patient as soon as samples become available.

Anybody have any clinical experience yet with this new medicine?

What a wonderful story! The representative was correct about the timing of approval. No clinical experience as of yet since samples are not available. Samples may be available as early as September. I look forward to hearing about your first patient!

Melissa Barnett, OD
 
  • Like
Reactions: susan resnick

Laurence Craig Thomas

ODwire.org Supporting Member
Sep 13, 2009
6,056
5,670
113
School/Org
University of Houston
City
Dallas
State
Tx
I asked the sales representative how he found me.

He said they looked at the pharmaceutical utilization rates for optometrists in Texas and all the reps started with the top 10 optometrists in their territories.

He said I was at the top of his top 10!

Go figure...
 

William R. Hall

ODwire.org Supporting Member
Jun 24, 2008
6,799
1,988
113
School/Org
PUCO
City
Bloomfield
State
NM
I asked the sales representative how he found me.

He said they looked at the pharmaceutical utilization rates for optometrists in Texas and all the reps started with the top 10 optometrists in their territories.

He said I was at the top of his top 10!

Go figure...
You Da Man LCT! No surprise to me.
 

susan resnick

ODwire.org Supporting Member
Jan 10, 2001
437
27
28
www.eyewise.com
School/Org
SUNY College of Optometry
City
New York / Roslyn
State
NY
The reps have all just completed their specialized training. They did make some preliminary contacts with doctors prior to training to introduce themselves!

They will be following up with a “detailing” meeting and sampling over the next month or so. None of us has had first hand experience with the product yet, but the investigators report excellent results and no more than the typical occasional stinging, burning very low adverse event rate. I have a list of patients waiting for this!

The representative for RVL came over today and did a lunch meeting with the staff.

He was cool young dude right out of college - said he had three days of training before today and I was his first call!

I told him not to worry - I would help him to learn about our profession.

He really seemed to appreciate that and we scheduled a meeting for two weeks from now.

He didn't even have samples to leave - said it just got approved 13 days ago.

Comically, my first patient after lunch had unilateral ptosis of unknown etiology. I told her of our lunch meeting and what was discussed in the office. She said that she wasn't surprised - she knew that God had sent her to me on this day and that I would take care of her problem.

She will be my first patient as soon as samples become available.

Anybody have any clinical experience yet with this new medicine?
 

Kenneth C Dzubey OD

ODwire.org Supporting Member
Feb 25, 2012
1,441
1,020
113
School/Org
University of Houston
City
El Paso
State
TX
I had a patient that noticed improvement in his ptosis. He was a chronic Afrin Nasal Spray user....same active ingredient but less concentration. Never connected the dots then. Maybe the nasal route could be beneficial in some patients.
 
  • Like
Reactions: Kristin Bartlett

AdminWolf

Site Administrator & Tech Lead
Staff member
Feb 24, 2001
15,370
2,797
113
School/Org
University of Michigan Medical School
City
Lake Oswego
State
OR
Thanks to everyone who attended -- an archive of the webinar is above at the top of the thread. Ask any follow-up questions in this thread.

-- ad
 

Michael I. Davis

ODwire.org Supporting Member
Feb 3, 2001
3,790
829
113
www.opti-care.com
School/Org
Pennsylvania College of Optometry
City
Eldersburg
State
MD
For a bilateral ptosis, would 2.5% phenylepherine be a good trial if instilled on one eye and noticed less ptosis, then the Upneeq should work (prior to having office samples)?
 

susan resnick

ODwire.org Supporting Member
Jan 10, 2001
437
27
28
www.eyewise.com
School/Org
SUNY College of Optometry
City
New York / Roslyn
State
NY
Sales rep came with drops and breakfast for the office yesterday.

Wrote my first prescription for the drops this morning!

In this ODwire.org webinar, Melissa Barnett, OD and Susan Resnick, OD will help us learn more about ptosis, including causes, diagnosis, treatment landscape, impact on patients, and opportunity for your practice.

Jason Bacharach, MD, will introduce the first and only FDA-approved pharmacologic treatment for acquired blepharoptosis, RVL-1201 (oxymetazoline hydrochloride ophthalmic solution), 0.1%, (brand name: Upneeq) including its mechanism of action and clinical data.

Ask questions in the thread below!

View attachment 28415
We are off to a great start! Patients are so impressed with the immediate improvement in cosmesis. I find myself looking at lids now as they enter the room. Amazing how we never really paid attention to this before!
 

Lloyd Pate

Well-Known Member
Jun 1, 2002
24,817
7,043
113
School/Org
UHCO
City
Houston
State
TX
Just be careful as to the etiology. A patient just called me with the results of her EMG. She has MG. I had to argue with several neurologist and finally convinced one to do the EMG. My patient said the neurologist said she did not thing it was MG at the start. After the EMG, she said I was right. The patient was antibody negative too.
 
  • Like
Reactions: Kenneth C Dzubey OD

Jeff Summers

ODwire.org Supporting Member
Oct 17, 2003
999
256
83
Visit site
School/Org
SCO
City
Cordova
State
TN
I have never seen a rep yet but have a patient with a persistent ptosis from Bells Palsy. How is this drug Rxd?

One drop per day for ? days. What supply is typical?

Thanks
 

Ken Elder

ODwire.org Supporting Member
Jan 6, 2003
17,579
3,442
113
School/Org
SUNY College of Optometry
City
Wallingford
State
CT
Upneeq.....another ultra expensive medication that no insurance plan covers.

Two thumbs down.
 

Kenneth C Dzubey OD

ODwire.org Supporting Member
Feb 25, 2012
1,441
1,020
113
School/Org
University of Houston
City
El Paso
State
TX
I have never seen a rep yet but have a patient with a persistent ptosis from Bells Palsy. How is this drug Rxd?

One drop per day for ? days. What supply is typical?

Thanks

NDC 73687-062-15 Carton of 15 single patient-use containers individually foil-pouched provided within a child-resistant zipper bag.

NDC 73687-062-32 Carton of 30 single patient-use containers individually foil-pouched provided within a child-resistant zipper bag.

^^^
As supplied.

1 drop/day in affected eye. Most pt's won't start noticing a change until about 6 wks. Just Rx 1 Carton #15 or #30 single use containers and give then refills you desire. Recall in 6+ wks to document

I don't know if it's effective in Bell's Palsy
 
Last edited:

Jeff Summers

ODwire.org Supporting Member
Oct 17, 2003
999
256
83
Visit site
School/Org
SCO
City
Cordova
State
TN
Good call Dr Dzubey!

Just got off the phone with the pharmacist at RVL. Upneeq is not indicated for the treatment of ptosis associated with Bell's palsy. He is going to send me a copy of the study results for patients with Bell's. I will post it later.
 

Jeff Summers

ODwire.org Supporting Member
Oct 17, 2003
999
256
83
Visit site
School/Org
SCO
City
Cordova
State
TN
Good call Dr Dzubey!

Just got off the phone with the pharmacist at RVL. Upneeq is not indicated for the treatment of ptosis associated with Bell's palsy. He is going to send me a copy of the study results for patients with Bell's. I will post it later.


Here is the paper they sent regarding Bell's and Upneeq.
 

Attachments

  • RVL Medical Information Response Document - Bell's Palsy.pdf
    96.9 KB · Views: 279
Luneau Technology USA